Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Clinical trial NCT06003621 · RECRUITING

Trial details

NCT number: NCT06003621
Sponsor: Omico
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2023-12-15
Primary completion: 2026-05-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.